These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32921794)

  • 1. A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis.
    Davies C; Wilson R; Appiah-Kusi E; Blest-Hopley G; Brammer M; Perez J; Murray RM; Allen P; Bossong MG; McGuire P; Bhattacharyya S
    Transl Psychiatry; 2020 Sep; 10(1):311. PubMed ID: 32921794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis: A Randomized Clinical Trial.
    Bhattacharyya S; Wilson R; Appiah-Kusi E; O'Neill A; Brammer M; Perez J; Murray R; Allen P; Bossong MG; McGuire P
    JAMA Psychiatry; 2018 Nov; 75(11):1107-1117. PubMed ID: 30167644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiol.
    Davies C; Bossong MG; Martins D; Wilson R; Appiah-Kusi E; Blest-Hopley G; Zelaya F; Allen P; Brammer M; Perez J; McGuire P; Bhattacharyya S
    Psychol Med; 2024 Apr; 54(5):993-1003. PubMed ID: 37845827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis.
    O'Neill A; Wilson R; Blest-Hopley G; Annibale L; Colizzi M; Brammer M; Giampietro V; Bhattacharyya S
    Psychol Med; 2021 Mar; 51(4):596-606. PubMed ID: 31994476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report.
    Davies C; Appiah-Kusi E; Wilson R; Blest-Hopley G; Bossong MG; Valmaggia L; Brammer M; Perez J; Allen P; Murray RM; McGuire P; Bhattacharyya S
    Eur Arch Psychiatry Clin Neurosci; 2022 Apr; 272(3):461-475. PubMed ID: 34480630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis.
    Appiah-Kusi E; Petros N; Wilson R; Colizzi M; Bossong MG; Valmaggia L; Mondelli V; McGuire P; Bhattacharyya S
    Psychopharmacology (Berl); 2020 Apr; 237(4):1121-1130. PubMed ID: 31915861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol attenuates insular activity during motivational salience processing in patients with early psychosis.
    Gunasekera B; Wilson R; O'Neill A; Blest-Hopley G; O'Daly O; Bhattacharyya S
    Psychol Med; 2023 Jul; 53(10):4732-4741. PubMed ID: 35775365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
    Fusar-Poli P; Crippa JA; Bhattacharyya S; Borgwardt SJ; Allen P; Martin-Santos R; Seal M; Surguladze SA; O'Carrol C; Atakan Z; Zuardi AW; McGuire PK
    Arch Gen Psychiatry; 2009 Jan; 66(1):95-105. PubMed ID: 19124693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk.
    Davies C; Bossong MG; Martins D; Wilson R; Appiah-Kusi E; Blest-Hopley G; Allen P; Zelaya F; Lythgoe DJ; Brammer M; Perez J; McGuire P; Bhattacharyya S
    Schizophr Bull Open; 2023 Jan; 4(1):sgad022. PubMed ID: 39145348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical Outcome.
    Modinos G; Allen P; Zugman A; Dima D; Azis M; Samson C; Bonoldi I; Quinn B; Gifford GWG; Smart SE; Antoniades M; Bossong MG; Broome MR; Perez J; Howes OD; Stone JM; Grace AA; McGuire P
    Schizophr Bull; 2020 Apr; 46(3):670-679. PubMed ID: 32227226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis.
    Wilson R; Bossong MG; Appiah-Kusi E; Petros N; Brammer M; Perez J; Allen P; McGuire P; Bhattacharyya S
    Transl Psychiatry; 2019 Aug; 9(1):203. PubMed ID: 31439831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis.
    Modinos G; Kempton MJ; Tognin S; Calem M; Porffy L; Antoniades M; Mason A; Azis M; Allen P; Nelson B; McGorry P; Pantelis C; Riecher-Rössler A; Borgwardt S; Bressan R; Barrantes-Vidal N; Krebs MO; Nordentoft M; Glenthøj B; Ruhrmann S; Sachs G; Rutten B; van Os J; de Haan L; Velthorst E; van der Gaag M; Valmaggia LR; McGuire P;
    JAMA Psychiatry; 2020 Feb; 77(2):190-200. PubMed ID: 31722018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study.
    Bloomfield MAP; Yamamori Y; Hindocha C; Jones APM; Yim JLL; Walker HR; Statton B; Wall MB; Lees RH; Howes OD; Curran VH; Roiser JP; Freeman TP
    Psychopharmacology (Berl); 2022 May; 239(5):1539-1549. PubMed ID: 35445839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study.
    Winton-Brown TT; Allen P; Bhattacharyya S; Borgwardt SJ; Fusar-Poli P; Crippa JA; Seal ML; Martin-Santos R; Ffytche D; Zuardi AW; Atakan Z; McGuire PK
    Neuropsychopharmacology; 2011 Jun; 36(7):1340-8. PubMed ID: 21412224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocin.
    Davies C; Martins D; Dipasquale O; McCutcheon RA; De Micheli A; Ramella-Cravaro V; Provenzani U; Rutigliano G; Cappucciati M; Oliver D; Williams S; Zelaya F; Allen P; Murguia S; Taylor D; Shergill S; Morrison P; McGuire P; Paloyelis Y; Fusar-Poli P
    Mol Psychiatry; 2024 May; 29(5):1241-1252. PubMed ID: 38243074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.
    Bhattacharyya S; Fusar-Poli P; Borgwardt S; Martin-Santos R; Nosarti C; O'Carroll C; Allen P; Seal ML; Fletcher PC; Crippa JA; Giampietro V; Mechelli A; Atakan Z; McGuire P
    Arch Gen Psychiatry; 2009 Apr; 66(4):442-51. PubMed ID: 19349314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal cerebral blood flow, executive functioning, and fronto-striatal functional connectivity in clinical high risk for psychosis.
    Hubl D; Schultze-Lutter F; Hauf M; Dierks T; Federspiel A; Kaess M; Michel C; Schimmelmann BG; Kindler J
    Schizophr Res; 2018 Nov; 201():231-236. PubMed ID: 29983268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
    Bhattacharyya S; Morrison PD; Fusar-Poli P; Martin-Santos R; Borgwardt S; Winton-Brown T; Nosarti C; O' Carroll CM; Seal M; Allen P; Mehta MA; Stone JM; Tunstall N; Giampietro V; Kapur S; Murray RM; Zuardi AW; Crippa JA; Atakan Z; McGuire PK
    Neuropsychopharmacology; 2010 Feb; 35(3):764-74. PubMed ID: 19924114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing.
    Bhattacharyya S; Crippa JA; Allen P; Martin-Santos R; Borgwardt S; Fusar-Poli P; Rubia K; Kambeitz J; O'Carroll C; Seal ML; Giampietro V; Brammer M; Zuardi AW; Atakan Z; McGuire PK
    Arch Gen Psychiatry; 2012 Jan; 69(1):27-36. PubMed ID: 22213786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters fronto-striatal resting-state connectivity.
    Grimm O; Löffler M; Kamping S; Hartmann A; Rohleder C; Leweke M; Flor H
    Eur Neuropsychopharmacol; 2018 Jul; 28(7):841-849. PubMed ID: 29887287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.